secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001193125-23-197742
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst CEO Patrick J. McEnany to retire by end of 2023; remains Chairman
--------------------------------------------------------------------------

- CEO Patrick J. McEnany informed board of intention to retire as CEO by end of 2023.
- McEnany will continue as non-executive Chairman of the Board after retirement.
- Board has retained a nationally recognized executive recruitment firm to find successor.
- McEnany stated retirement not due to any disagreement with management or board.
- McEnany remains Catalyst's largest individual stockholder.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523197742/0001193125-23-197742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523197742/d538695d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-197742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer